Autogenic versus reciprocal inhibitio
Not Applicable
Recruiting
- Conditions
- Nervous System Diseasesspasticity
- Registration Number
- PACTR201801002940240
- Lead Sponsor
- faculty of physical therapy cairo university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Forty spastic hemiplegic CP children of both sexes.
ages were ranged from 7 to 9 years.
They had grade 1 or 1+ according to modified Ashworth scale and grade II or III according to Manual Ability Classification Scale (MACS). they can understand and follow verbal commands and instructions included in the test.
Exclusion Criteria
More than grade 1 or 1+ according to modified Ashworth scale
more than grade II or III according to Manual Ability Classification Scale (MACS)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate autogenic inhibition from reciprocal inhibition in managing pediatric spasticity?
How does autogenic inhibition compare to standard physical therapy interventions for spastic cerebral palsy in children?
Which neurological biomarkers correlate with improved motor outcomes in PACTR201801002940240 spasticity trials?
What adverse events are reported in autogenic inhibition versus reciprocal inhibition techniques for spastic children?
Are there combination therapies with autogenic inhibition enhancing spasticity reduction in pediatric neurorehabilitation?